+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Molecular Infectious Disease Testing Market - Global Forecast 2026-2032- Product Image
Molecular Infectious Disease Testing Market - Global Forecast 2026-2032- Product Image
Sale

Molecular Infectious Disease Testing Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6090260
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Molecular Infectious Disease Testing Market is projected to reach USD 10.43 Billion in 2026. It is expected to continue growing at a CAGR of 10.77%, reaching USD 19.34 Billion by 2032.

Molecular Infectious Disease Testing: Executive Overview

Molecular infectious disease testing uses nucleic-acid technologies, including polymerase chain reaction and other amplification methods, to detect pathogens or pathogen-specific genetic material. Its clinical value is strongest where rapid, sensitive, and targeted diagnosis can guide treatment, infection-control decisions, surveillance, and public-health response. The field spans respiratory, gastrointestinal, sexually transmitted, blood-borne, healthcare-associated, and emerging infections across hospitals, laboratories, clinics, and decentralized care settings.

From Centralized Diagnosis to Connected, Decentralized Care

The landscape is shifting from centralized laboratory workflows toward integrated diagnostic networks that combine high-throughput platforms with near-patient and point-of-care testing. Multiplex panels can support differential diagnosis, while automation, connectivity, and standardized workflows improve operational consistency. Adoption is also shaped by antimicrobial-resistance surveillance, outbreak preparedness, laboratory capacity, reimbursement rules, procurement practices, and the need to maintain performance across varied specimen types and care environments.

Artificial Intelligence Strengthens Interpretation and Workflow Management

Artificial intelligence can contribute to molecular infectious disease testing through result interpretation, quality-control monitoring, anomaly detection, laboratory scheduling, and integration of test results with clinical and epidemiological information. Its practical impact depends on representative training data, transparent validation, cybersecurity, human oversight, and clear accountability for incorrect or uncertain outputs. AI is most useful when it augments qualified laboratory and clinical judgment rather than replacing analytical validation or established biosafety procedures.

Regional Insights: Uneven Capacity, Shared Preparedness Priorities

North America emphasizes rapid diagnostics, laboratory automation, antimicrobial-resistance monitoring, and integration with electronic health records. Europe combines strong laboratory networks with regulatory and cross-border data requirements. Asia-Pacific presents substantial diversity, ranging from advanced urban laboratory systems to settings where access, logistics, and workforce availability remain constraints. Latin America continues to prioritize decentralized access, surveillance, and dependable supply chains. The Middle East is strengthening specialized hospital and reference-laboratory capacity, while Africa focuses on expanding testing access, specimen transport, workforce capability, and outbreak-response infrastructure.

Group Insights: Trade, Regulation, and Security Shape Adoption

ASEAN markets commonly face differences in laboratory maturity, procurement systems, and regulatory alignment, making interoperability and regional preparedness important. BRICS members reflect varied public-health priorities and domestic manufacturing capabilities, with collaboration relevant to access and resilience. The European Union emphasizes harmonized regulation, surveillance, and cross-border health-data exchange. G7 countries generally prioritize advanced diagnostics, biosecurity, and innovation governance. GCC countries are strengthening centralized and hospital-based capacity, while NATO members place additional emphasis on health security, interoperability, and readiness for biological threats.

Country Insights: Diverse Priorities Across Major Testing Systems

Australia emphasizes geographically distributed access, surveillance, and laboratory quality; Brazil balances broad public-health needs with regional access challenges. Canada prioritizes networked public-health laboratories and remote-service delivery, while China continues expanding diagnostic capacity and digital health integration. France, Germany, Italy, Spain, and the United Kingdom focus on laboratory quality, antimicrobial resistance, preparedness, and coordinated healthcare delivery. India combines large-scale diagnostic demand with efforts to widen access and strengthen domestic capacity. Japan and South Korea emphasize automation, quality systems, and rapid response. Mexico continues to address uneven regional access and surveillance needs. Russia’s priorities include national laboratory capability and infectious-disease monitoring. The United States focuses on advanced molecular workflows, decentralized testing, healthcare integration, and public-health preparedness.

Actions for Leaders: Build Resilient, Clinically Integrated Testing Networks

Industry leaders should align assay portfolios with clearly defined clinical and public-health use cases, validate performance across relevant populations and specimens, and design workflows for both centralized and decentralized settings. Investments should prioritize interoperability, cybersecurity, quality management, workforce training, supply-chain resilience, and transparent evidence generation. Organizations adopting AI should establish governance, monitor performance across demographic and geographic groups, preserve human review, and document model changes. Partnerships with laboratories, clinicians, public-health agencies, and procurement authorities can improve implementation and ensure that testing contributes to appropriate treatment and surveillance decisions.

Research Methodology: Evidence-Based Assessment of Molecular Testing Dynamics

This executive summary is structured around the supplied market definition and the required geographic and economic groupings. It synthesizes established, data-backed themes in molecular diagnostics, including technology development, laboratory operations, clinical utility, public-health surveillance, regulation, infrastructure, and digital integration. Regional, group, and country narratives are comparative and qualitative; they avoid market estimates, market shares, forecasts, and unsupported company-specific claims. Conclusions should be interpreted alongside current regulatory guidance, peer-reviewed evidence, laboratory standards, and jurisdiction-specific public-health data.

Conclusion: Reliable Molecular Testing Depends on Integration and Trust

Molecular infectious disease testing is becoming a core component of modern diagnosis, surveillance, and preparedness. Its benefits depend not only on assay sensitivity or platform speed, but also on appropriate clinical use, accessible infrastructure, validated workflows, skilled personnel, secure data exchange, and resilient supply chains. The strongest long-term strategies will connect laboratory innovation with public-health priorities while applying AI cautiously, maintaining scientific transparency, and preserving expert oversight.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Molecular Infectious Disease Testing Market, by Product Type
7.1. Introduction
7.2. Instruments
7.3. Reagents & Kits
7.4. Software & Services
8. Molecular Infectious Disease Testing Market, by Technology
8.1. Introduction
8.2. DNA Microarrays
8.3. DNA Sequencing & Next-Generation Sequencing
8.4. In Situ Hybridization
8.5. Isothermal Nucleic Acid Amplification Technology
8.6. Polymerase Chain Reaction
9. Molecular Infectious Disease Testing Market, by Pathogen Type
9.1. Introduction
9.2. Bacterial
9.3. Fungal
9.4. Parasitic
9.5. Viral
10. Molecular Infectious Disease Testing Market, by Specimen Type
10.1. Introduction
10.2. Blood
10.3. Respiratory
10.4. Stool
10.5. Urine
11. Molecular Infectious Disease Testing Market, by Application
11.1. Introduction
11.2. Diagnostic Testing
11.3. Epidemiological Investigations
11.4. Screening Testing
11.5. Therapeutic Monitoring
12. Molecular Infectious Disease Testing Market, by End Users
12.1. Introduction
12.2. Diagnostic Laboratories
12.3. Hospitals & Clinics
12.4. Research Institutes
13. Molecular Infectious Disease Testing Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Molecular Infectious Disease Testing Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Molecular Infectious Disease Testing Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Agilent Technologies, Inc.
17.3. Altona Diagnostics GmbH
17.4. Becton, Dickinson and Company
17.5. Bio-Rad Laboratories, Inc.
17.6. BioFire Diagnostics, LLC
17.7. bioMérieux SA
17.8. Cepheid by Danaher Corporation
17.9. Eurofins Viracor LLC
17.10. F. Hoffmann-La Roche Ltd
17.11. GenScript Biotech Corporation
17.12. Grifols S.A.
17.13. Hologic Inc.
17.14. Illumina, Inc.
17.15. Luminex Corporation
17.16. Merck KGaA
17.17. Myriad Genetics, Inc.
17.18. Novacyt Group
17.19. PerkinElmer, Inc.
17.20. Qiagen N.V.
17.21. QuidelOrtho Corporation
17.22. Seegene Inc.
17.23. Siemens Healthineers
17.24. Sysmex Corporation
17.25. Thermo Fisher Scientific, Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Molecular Infectious Disease Testing Market, Years Considered for the Study
FIGURE 2. Global Molecular Infectious Disease Testing Market, Research Design
FIGURE 3. Global Molecular Infectious Disease Testing Market, Research Framework
FIGURE 4. Global Molecular Infectious Disease Testing Market, Data Triangulation
FIGURE 5. Global Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Molecular Infectious Disease Testing Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Molecular Infectious Disease Testing Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Molecular Infectious Disease Testing Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Molecular Infectious Disease Testing Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2025 vs 2032 (%)
FIGURE 11. Global Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Molecular Infectious Disease Testing Market Size, by Specimen Type, 2025 vs 2032 (%)
FIGURE 13. Global Molecular Infectious Disease Testing Market Size, by Specimen Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Molecular Infectious Disease Testing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Molecular Infectious Disease Testing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Molecular Infectious Disease Testing Market Size, by End Users, 2025 vs 2032 (%)
FIGURE 17. Global Molecular Infectious Disease Testing Market Size, by End Users, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Molecular Infectious Disease Testing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Molecular Infectious Disease Testing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Molecular Infectious Disease Testing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Molecular Infectious Disease Testing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Molecular Infectious Disease Testing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Molecular Infectious Disease Testing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Molecular Infectious Disease Testing Market Segmentation & Coverage
TABLE 2. Global Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Reagents & Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Reagents & Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Reagents & Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Software & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Software & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Software & Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 14. Global DNA Microarrays Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global DNA Microarrays Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global DNA Microarrays Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global DNA Sequencing & Next-Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global DNA Sequencing & Next-Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global DNA Sequencing & Next-Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global In Situ Hybridization Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global In Situ Hybridization Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global In Situ Hybridization Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Isothermal Nucleic Acid Amplification Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Isothermal Nucleic Acid Amplification Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Isothermal Nucleic Acid Amplification Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 30. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Fungal Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Fungal Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Fungal Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Parasitic Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Parasitic Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Parasitic Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Viral Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Viral Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Viral Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 43. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Respiratory Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Respiratory Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Respiratory Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Stool Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Stool Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Stool Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 56. Global Diagnostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Diagnostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Diagnostic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Epidemiological Investigations Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Epidemiological Investigations Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Epidemiological Investigations Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Screening Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Screening Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Screening Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Therapeutic Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Therapeutic Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Therapeutic Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 69. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Molecular Infectious Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Molecular Infectious Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 86. North America Molecular Infectious Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. North America Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 88. North America Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 89. North America Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 90. North America Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 91. North America Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. North America Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 93. Latin America Molecular Infectious Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Latin America Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 95. Latin America Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 96. Latin America Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 97. Latin America Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 98. Latin America Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. Latin America Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 100. Europe Molecular Infectious Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Europe Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. Europe Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 103. Europe Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 104. Europe Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 105. Europe Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. Europe Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 107. Middle East Molecular Infectious Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Middle East Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 109. Middle East Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 110. Middle East Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 111. Middle East Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 112. Middle East Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Middle East Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 114. Africa Molecular Infectious Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Africa Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 116. Africa Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 117. Africa Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 118. Africa Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 119. Africa Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. Africa Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 121. Global Molecular Infectious Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. ASEAN Molecular Infectious Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. ASEAN Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. ASEAN Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 125. ASEAN Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 126. ASEAN Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 127. ASEAN Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. ASEAN Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 129. GCC Molecular Infectious Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. GCC Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 131. GCC Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 132. GCC Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 133. GCC Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 134. GCC Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. GCC Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 136. European Union Molecular Infectious Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. European Union Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. European Union Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 139. European Union Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 140. European Union Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 141. European Union Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. European Union Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 143. BRICS Molecular Infectious Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. BRICS Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. BRICS Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 146. BRICS Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 147. BRICS Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 148. BRICS Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. BRICS Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 150. G7 Molecular Infectious Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. G7 Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 152. G7 Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 153. G7 Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 154. G7 Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 155. G7 Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. G7 Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 157. NATO Molecular Infectious Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. NATO Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 159. NATO Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 160. NATO Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 161. NATO Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 162. NATO Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. NATO Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 164. Global Molecular Infectious Disease Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. United States Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 166. United States Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 167. United States Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 168. United States Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 169. United States Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 170. United States Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. United States Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 172. Canada Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 173. Canada Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. Canada Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 175. Canada Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 176. Canada Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 177. Canada Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. Canada Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 179. Mexico Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 180. Mexico Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. Mexico Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 182. Mexico Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 183. Mexico Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 184. Mexico Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Mexico Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 186. Brazil Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 187. Brazil Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. Brazil Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 189. Brazil Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 190. Brazil Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 191. Brazil Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Brazil Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 193. United Kingdom Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 194. United Kingdom Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 195. United Kingdom Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. United Kingdom Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 197. United Kingdom Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 198. United Kingdom Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. United Kingdom Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 200. Germany Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 201. Germany Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. Germany Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 203. Germany Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 204. Germany Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 205. Germany Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. Germany Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 207. France Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 208. France Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. France Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 210. France Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 211. France Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 212. France Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. France Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 214. Russia Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 215. Russia Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. Russia Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 217. Russia Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 218. Russia Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 219. Russia Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Russia Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 221. Italy Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 222. Italy Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 223. Italy Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. Italy Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 225. Italy Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 226. Italy Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Italy Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 228. Spain Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 229. Spain Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. Spain Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 231. Spain Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 232. Spain Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 233. Spain Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. Spain Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 235. China Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 236. China Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 237. China Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 238. China Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 239. China Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 240. China Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. China Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 242. India Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 243. India Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 244. India Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 245. India Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 246. India Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 247. India Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. India Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 249. Japan Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 250. Japan Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 251. Japan Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 252. Japan Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 253. Japan Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 254. Japan Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. Japan Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 256. Australia Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 257. Australia Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 258. Australia Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 259. Australia Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 260. Australia Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 261. Australia Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Australia Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 263. South Korea Molecular Infectious Disease Testing Market Size, 2017-2032 (USD Million)
TABLE 264. South Korea Molecular Infectious Disease Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 265. South Korea Molecular Infectious Disease Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 266. South Korea Molecular Infectious Disease Testing Market Size, by Pathogen Type, 2017-2032 (USD Million)
TABLE 267. South Korea Molecular Infectious Disease Testing Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 268. South Korea Molecular Infectious Disease Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. South Korea Molecular Infectious Disease Testing Market Size, by End Users, 2017-2032 (USD Million)
TABLE 270. Global Molecular Infectious Disease Testing Market Share, by Key Player, 2025
TABLE 271. Global Molecular Infectious Disease Testing Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Altona Diagnostics GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioFire Diagnostics, LLC
  • bioMérieux SA
  • Cepheid by Danaher Corporation
  • Eurofins Viracor LLC
  • F. Hoffmann-La Roche Ltd
  • GenScript Biotech Corporation
  • Grifols S.A.
  • Hologic Inc.
  • Illumina, Inc.
  • Luminex Corporation
  • Merck KGaA
  • Myriad Genetics, Inc.
  • Novacyt Group
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • QuidelOrtho Corporation
  • Seegene Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

Related Topics

Related Reports

Healthcare-associated Infectious Disease Diagnostics Market - Global Forecast 2026-2032 - Product Image

Healthcare-associated Infectious Disease Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Infectious Diseases In-Vitro Diagnostics Market - Global Forecast 2026-2032 - Product Image

Infectious Diseases In-Vitro Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Point-of-Care Infectious Disease Diagnostics - Global Strategic Business Report - Product Image

Point-of-Care Infectious Disease Diagnostics - Global Strategic Business Report

  • Report
  • 287 Pages
  • Global
From
Molecular Infectious Disease Diagnostics Market - Strategic Insights and Forecasts (2026-2035) - Product Image

Molecular Infectious Disease Diagnostics Market - Strategic Insights and Forecasts (2026-2035)

  • Report
  • 171 Pages
  • Global
From
Molecular Infectious Disease Testing Market by Product & Service, Type, Test Type, Disease, Technology, End User - Global Forecast to 2031 - Product Image

Molecular Infectious Disease Testing Market by Product & Service, Type, Test Type, Disease, Technology, End User - Global Forecast to 2031

  • Report
  • 469 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.